AU4404785A - Ltr vectors, methods of preparation and use - Google Patents

Ltr vectors, methods of preparation and use

Info

Publication number
AU4404785A
AU4404785A AU44047/85A AU4404785A AU4404785A AU 4404785 A AU4404785 A AU 4404785A AU 44047/85 A AU44047/85 A AU 44047/85A AU 4404785 A AU4404785 A AU 4404785A AU 4404785 A AU4404785 A AU 4404785A
Authority
AU
Australia
Prior art keywords
preparation
methods
ltr vectors
ltr
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44047/85A
Inventor
William A Haseltine
Craig A Rosen
Jack R Lenz
Daniel W Celander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of AU4404785A publication Critical patent/AU4404785A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU44047/85A 1984-05-25 1985-05-24 Ltr vectors, methods of preparation and use Abandoned AU4404785A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61427484A 1984-05-25 1984-05-25
US614274 1984-05-25

Publications (1)

Publication Number Publication Date
AU4404785A true AU4404785A (en) 1985-12-31

Family

ID=24460550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44047/85A Abandoned AU4404785A (en) 1984-05-25 1985-05-24 Ltr vectors, methods of preparation and use

Country Status (4)

Country Link
EP (1) EP0181930A1 (en)
JP (1) JPS61502932A (en)
AU (1) AU4404785A (en)
WO (1) WO1985005629A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1310924C (en) * 1986-04-24 1992-12-01 Francis P. Mccormick Infective drug delivery system
US5928637A (en) * 1987-06-16 1999-07-27 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods of inducing multidrug resistance using human MDR1 cDNA
US5851819A (en) * 1987-06-16 1998-12-22 National Institutes Of Health Vectors carrying MDR1 cDNA which confer multidrug resistance on transduced cells
DE3723075A1 (en) * 1987-07-11 1989-01-19 Boehringer Mannheim Gmbh EUKARYOTIC EXPRESSION VECTORS WITH MULTIMERAL ENHANCER SUBELEMENTS, METHOD FOR THEIR PRODUCTION AND USE
US5716826A (en) * 1988-03-21 1998-02-10 Chiron Viagene, Inc. Recombinant retroviruses
US6569679B1 (en) 1988-03-21 2003-05-27 Chiron Corporation Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
US6133029A (en) * 1988-03-21 2000-10-17 Chiron Corporation Replication defective viral vectors for infecting human cells
US5662896A (en) 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
US6241982B1 (en) 1988-03-21 2001-06-05 Chiron Corporation Method for treating brain cancer with a conditionally lethal gene
ATE199398T1 (en) * 1989-10-24 2001-03-15 Chiron Corp SECRETION OF HUMAN PROTEIN BONDED WITH GAMMA INTERFERON SIGNAL PEPTIDE
NL9001828A (en) * 1990-08-15 1992-03-02 Centraal Diergeneeskundig Inst METHOD FOR CHANGING THE CELL, TISSUE, OR HOST TRPISM OF A MICRO-ORGANISM; SO OBTAINED RECOMBINED MICROORGANISM AND ITS APPLICATION IN MEDICINE AND VETERINARY.
US5580564A (en) * 1990-08-15 1996-12-03 Akzo Nobel N.V. Method for modifying the cell, tissue or host tropism of microorganisms; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine
CA2158936C (en) 1993-11-18 2012-02-21 Jack R. Barber Compositions and methods for utilizing conditionally lethal genes
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
US8877896B2 (en) 2008-02-15 2014-11-04 Tufts University Compositions, methods and kits for modeling, diagnosing, and treating complement disorders
US8324182B2 (en) 2008-02-15 2012-12-04 Tufts University Humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
CA2843684A1 (en) 2010-08-13 2012-02-16 Tufts University Compositions, kits and methods for treatment of macular degeneration using soluble membrane-independent cd59 protein
EP3892291A1 (en) 2014-08-28 2021-10-13 Tufts University Compositions, methods and kits for treating complement related disorders
JP7430394B2 (en) 2018-02-12 2024-02-13 トラスティーズ オブ タフツ カレッジ CD59 to inhibit inflammasome activation
WO2023089564A1 (en) 2021-11-19 2023-05-25 Janssen Biotech, Inc. Method of treating geographic atrophy with a gene therapy vector expressing soluble cd59

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors

Also Published As

Publication number Publication date
JPS61502932A (en) 1986-12-18
WO1985005629A1 (en) 1985-12-19
EP0181930A1 (en) 1986-05-28

Similar Documents

Publication Publication Date Title
EP0220693A3 (en) Acylamino silicon compounds, their use and preparation
ZA882452B (en) Use of n,n-dialkylhydroxylamines and their preparation
AU8215687A (en) Adhesives, their preparation and use
AU4404785A (en) Ltr vectors, methods of preparation and use
AU562064B2 (en) Preparation of gallosilicates and use as catalysts
AU582662B2 (en) Repeating block, oligomer-free, polyphase, thermoformable polyurethanes and method of preparation thereof
DE3571454D1 (en) Reactive dyes of the dioxazine-type, their preparation and use
AU590346B2 (en) Process for the preparation of halogenated (2,2)- paracyclophanes and mixtures of resultant halogenated (2,2)-paracyclophanes
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU2702288A (en) New quaternary ammonium compounds, their preparation and use
EP0256608A3 (en) Method of preparation and use of solid, phytoactive compositions
AU573330B2 (en) Preparation and separation of ammonia
GB2183638B (en) Polyfluoroalkylisoxazolylamines, their preparation and use
AU4638085A (en) Therepautic preparations fortreatment of certain viral and other diseases and the preparation of the same
AU2636384A (en) Phenylaminobenzenealkanols and preparation
ZA852459B (en) Derivatives of hydroxy-4-2h-1-benzothiopyran-2-one,their preparation and applications
AU6292286A (en) N-substituted-3,4,5,6,-tetrahydrophthalimides, their preparation and use
AU576717B2 (en) N6 - bicycloadenosines and methods of use
GB2159817B (en) Preparation of amidohydroxycephams, novel aminoacyloxycephams and derivatives thereof
AU578739B2 (en) Vinyltetrazolylphenyl derivatives, their preparation and their use
AU4453185A (en) Modified zsm-5 catalyst, and method of preparation and use thereof
AU8129987A (en) Pyrrolo-benzimidazoles, their preparation and use
AU574852B2 (en) 13 - acyloxy - 5 - ketomilbemycin derivatives and preparation of 13 - hydroxy - 5 - ketomilbemycin derivatives
AU8133487A (en) Preparation of 2-nitro- substituted phenoxy (alkylsulphonyl benzamides)
AU584123B2 (en) New hydroxy-thia alkenes, their process of preparation and uses